Das Klinikum

Prof. Dr. med. Jürgen Schreieck

Prof. Dr. med. Jürgen Schreieck

Ltd Oberarzt

Leitender Oberarzt
Personal-Oberarzt der Klinik für Kardiologie und Angiologie
Leiter der Ausbildungsstätte Spezielle Rhythmologie (DKG-zertifiziert, invasive Elektrophysiologie und aktive Herzrhythmusimplantate)
Leiter des EPU-Katheterlabors

Kontakt

Telefonnummer: Wlan Telefon: 07071 29-68781

Telefonnummer: EPU-Labor: 07071 29-80642

Faxnummer: Fax: 07071-294550

E-Mail-Adresse: juergen.schreieck@med.uni-tuebingen.de

Klinik / Institut / Zentrum

  • Interventionelle Kardiologie (DKG)
  • Spezielle Rhythmologie - invasive Elektrophysiologie und Katheterablation (DGK-zertifiziert)
  • Spezielle Rhythmologie - Aktive Rhythmusimplantate (DGK-zertifiziert)
  • Zertifizierungen für PFO/ASD- und LAA-Verschluss-System
  • Zertifizierungen für percutane Mitral- und Tricuspidalklappenrekonstruktionen
  • Zertifizierung für percutane Mitralklappenanuloplastie
  • Katheterablation von Herzrhythmusstörungen
  • Klinische Rhythmologie
  • Katheterbasierte AV-Klappenrekonstruktionen
  • 1987-1992Studium Humanmedizin an der Ruprecht-Karls-Universität Heidelberg
  • 1992-1993Studium/Praktisches Jahr an der Ludwigs-Maximilians-Universität München
  • 12/93-05/95Institut für Pharmakologie und Toxikologie und I. Med. Klinik (Kardiologie), Klinikum r. d. Isar, TU München
  • 1995-1998Medizinische Kliniken, Klinikum rechts der Isar, TU München (Kardiologie, Intensivmedizin, Pulmologie, Gastroenterologie)
  • 02/98-10/2004Klinik für Herz-Kreislauferkrankungen, Deutsches Herzzentrum München an der Technischen Universität München (Rhythmusstation, Intensivmedizin, Herzkatheterlabor, EPU-Katheterlabor, SM/ICD-Ambulanz und Implantation
  • 11/2004-heuteOberarzt der Inneren Medizin III, Abteilung für Kardiologie und Angiologie, Leiter der EPU-Katheterlabors
  • Röntgenstrahlenfreie Katheterablation und Vorhofflimmerablation
  • Publikationsverzeichnis1. Deep sedation in a patient undergoing transfemoral tricuspid valve repair using the PASCAL system. Arikan MX, Jorbenadze R, MD, Tavlaki E, Schreieck J, Geisler T, JACC:CASE REPORTS 2020; J Am Coll Cardiol Case Rep 2020;2:1109–11.2. Video assisted thoracoscopic sympathectomy for intractable recurrent VT after minimal-invasive LVAD implantation. Salewski C, Nemeth A, Sandoval Boburg R, Steger V, Krüger T, Schreieck J, Schlensak C, Popov AF. J Card Surg. 2020 Jul;35(7):1708-1710. doi: 10.1111/jocs.146393. Ventrikuläre Arrhythmien bei Myokarditis und inflammatorischer Kardiomyopathie. Schreieck J, Seizer, P. Kardiologie up2date 2019; 15(04): 335-352. DOI: 10.1055/a-0710-7023.4. Cryoballoon ablation for persistent atrial fibrillation in patients without left atrial fibrosis. Gramlich M, Maleck C, Marquardt J, Duckheim M, Stimpfle F, Heinzmann D, Scheckenbach C, Gawaz M, Schreieck J*, Seizer P*, authors contributed equally and share last authorship. J Cardiovasc Electrophysiol. 2019 Jul;30(7):999-1004. doi: 10.1111/jce.13936. Epub 2019 Apr 115. Thrombogenicity and Antithrombotic Strategies in Structural Heart Interventions and Nonaortic Cardiac Device Therapy-Current Evidence and Practice. Geisler T, Jorbenadze R, Popov AF, Mueller KL, Rath D, Droppa M, Schreieck J, Seizer P, Storey RF, Kristensen SD, Rubboli A, Gorog D, Aradi D, Sibbing D, Huber K, Gawaz M, Ten Berg J. Thromb Haemost. 2019 Oct;119(10):1590-1605. doi: 10.1055/s-0039-1694751. Epub 2019 Aug 17.6. Conventional echocardiographic parameters or three-dimensional echocardiography to evaluate right ventricular function in percutaneous edge-to-edge mitral valve repair (PMVR). Sauter RJ, Patzelt J, Mezger M, Nording H, Reil JC, Saad M, Seizer P, Schreieck J, Rosenberger P, Langer HF, Magunia H. Int J Cardiol Heart Vasc. 2019 Aug 30;24:100413. doi: 10.1016/j.ijcha.2019.100413. eCollection 2019 Sep.7. ECG changes after percutaneous edge-to-edge mitral valve repair. Bo H, Heinzmann D, Grasshoff C, Rosenberger P, Schlensak C, Gawaz M, Schreieck J, Langer HF, Patzelt J, Seizer P. Clin Cardiol. 2019 Nov;42(11):1094-1099. doi: 10.1002/clc.23258. Epub 2019 Sep 9.8. Elevated Mitral Valve Pressure Gradient is predictive for long-term outcome after Percutaneous Edge-to-edge Mitral Valve Repair (PMVR) in patients with degenerative MR, but not in functional MR. Patzelt J, Zhang W, Sauter R, Mezger M, Nording H, Ulrich M, Becker A, Patzelt T, Rudolph V, Eitel I, Saad M, Bamberg F, Schlensak C, Gawaz M, Boekstegers P, Schreieck J, Seizer P, Langer HF. JAHA: Journal of the American Heart Association 2019, accepted Manuscript #JAHA/2018/011366R1.9. Mitochondrial Dynamics in Tachycardiomyopathy. Heinzmann D, Klingel K, Müller K, Kumbrink J, Kirchner T, Schreieck J, Gawaz M, Seizer P. Cell Physiol Biochem. 2019;52:435-438.210. Treatment of a patient with primary mitral regurgitation using the Cardioband®system. Götz N, Schreieck J, Langer HF, Patzelt J. Eur Heart J Case Rep. 2019 Jun1;3(2):ytz028. doi: 10.1093/ehjcr/ytz028.11. Peri-interventional combined anticoagulation and antithrombotic therapy in atrialfibrillation ablation: A retrospective safety analysis. Klee K, Widulle D, Duckheim M,Gramlich M, Frische C, Gawaz M, Seizer P, Eick C, Schreieck J. Cardiol J.2018;25:213-220.12. Previous TAVR in patients undergoing percutaneous edge-to-edge mitral valve repair(PMVR) affects improvement of MR. Patzelt J, Ulrich M, Becker A, Müller KAL,Jorbenadze R, Droppa M, Zhang W, Mandel S, Habel L, Lausberg H, Pöss J, GeislerT, Borst O, Rosenberger P, Schlensak C, Gawaz M, Schreieck J, Seizer P, LangerHF. PLoS One. 2018;13:e0205930. doi: 10.1371/journal.pone.0205930.13. TGFβ Is Specifically Upregulated on Circulating CD14++ CD16+ and CD14+ CD16++Monocytes in Patients with Atrial Fibrillation and Severe Atrial Fibrosis. Heinzmann D,Fuß S, Ungern-Sternberg SV, Schreieck J, Gawaz M, Gramlich M, Seizer P. CellPhysiol Biochem. 2018;49:226-234.14. Percutaneous Edge-to-Edge Mitral Valve Repair Using the New MitraClipXTR System. Jorbenadze R, Schreieck J, Barthel C, Seizer P, Schlensak C, GawazM, Patzelt J, Langer HF. JACC Cardiovasc Interv. 2018;11:e93-e95.15. Prognostic Value of Atrial Fibrillation Inducibility in Patients Without History of AtrialFibrillation. Marquardt J, Marquardt K, Scheckenbach C, Zhang W, Stimpfle F,Duckheim M, Maleck C, Seizer P, Gawaz M, Schreieck J, Gramlich M. J AtrFibrillation 2018;11:1837.eCollection 2018 Jun-Jul.16. Circulating MicroRNA-21 Correlates With Left Atrial Low-Voltage Areas and IsAssociated With Procedure Outcome in Patients Undergoing Atrial FibrillationAblation.. Zhou Q, Maleck C, von Ungern-Sternberg SNI, Neupane B, Heinzmann D,Marquardt J, Duckheim M, Scheckenbach C, Stimpfle F, Gawaz M, Schreieck J,Seizer P, Gramlich M. Circ Arrhythm Electrophysiol. 2018;11:e006242.17. Histopathological and Immunological Characteristics of Tachycardia-InducedCardiomyopathy Mueller KAL, Heinzmann D, Klingel K, Fallier-Becker P, Kandolf R,Kilias A, Walker-Allgaier B, Borst O, Kumbrink J, Kirchner T, Langer H, Geisler T,Schreieck J, Gramlich M, Gawaz M, Seizer P. J Am Coll Cardiol. 2017;69:2160-2172.18. Apixaban for treatment of embolic stroke of undetermined source (ATTICUSrandomized trial): Rationale and study design. Geisler T, Poli S, Meisner C,Schreieck J, Zuern CS, Nägele T, Brachmann J, Jung W, Gahn G, Schmid E,Bäezner H, Keller T, Petzold GC, Schrickel JW, Liman J, Wachter R, Schön F,Schabet M, Lindner A, Ludolph AC, Kimmig H, Jander S, Schlegel U, Gawaz M,Ziemann U. Int J Stroke. 2017;12:985-990.19. Immediate increase of cardiac output after percutaneous mitral valve repair (PMVR)determined by echocardiographic and invasive parameters: Patzelt: Increase ofcardiac output after PMVR. Patzelt J, Zhang Y, Magunia H, Jorbenadze R, Droppa M,Ulrich M, Cai S, Lausberg H, Walker T, Wengenmayer T, Rosenberger P, SchreieckJ, Seizer P, Gawaz M, Langer HF. Int J Cardiol. 2017;236:356-362.320. Formation of a left atrial thrombus during percutaneous mitral valve edge-to-edgerepair induced by acute reduction of mitral regurgitation. Glatthaar A, Seizer P,Patzelt J, Langer H, Schreieck J, Gawaz M. J Cardiol Cases. 2017;17:33-35.21. Percutaneous Mitral Valve Edge-to-Edge Repair Assisted by Hemodynamic SupportDevices: A Case Series of Bailout Procedures. Seizer P, Schibilsky D, Sauter R,Schreieck J, Lausberg H, Walker T, Gawaz M, Langer HF, Schlensak C. Circ HeartFail. 2017;10:e004051.22. Percutaneous Mitral Valve Edge-to-Edge Repair Using Volume IntracardiacEchocardiography-First in Human Experience. Patzelt J, Schreieck J, Camus E,Gawaz M, Seizer P, Langer HF. CASE (Phila). 2017;1:41-43.23. Thromboembolic Risk Reduction Via Transseptal Thrombus Aspiration in a PatientWith Spontaneous Left Atrial Thrombus and Stroke. Stimpfle F, Müller K, Geisler T,Schreieck J, Schlak D, Ziemann U, Gawaz M, Seizer P. JACC Cardiovasc Interv.2017;10:e57-e59.24. Comparison of ventricular inducibility with late gadolinium enhancement andmyocardial inflammation in endomyocardial biopsy in patients with dilatedcardiomyopathy. Mueller KA, Heck C, Heinzmann D, Schwille J, Klingel K, Kandolf R,Kramer U, Gramlich M, Geisler T, Gawaz M, Schreieck J* and Seizer P*, *authorscontributed equally and share last authorship, PLOS ONE2016,,11:e0167616.doi:10.137125. Ablation of an electrical storm in a patient with giant cell myocarditis using continuousflow left ventricular assist device and percutaneous right ventricular assist device.Heinzmann D, Schibilsky D, Gramlich M, Klingel K, Kandolf R, Rosenberger P,Gawaz M, Schreieck J, Schlensak C, Seizer P. Int J Cardiol. 2016;209:84-6.26. Efficacy and safety of zero-fluoroscopy ablation for supraventricular tachycardias.Use of optional contact force measurement for zero-fluoroscopy ablation in a clinicalroutine setting. Seizer P, Bucher V, Frische C, Heinzmann D, Gramlich M, Müller I,Henning A, Hofbeck M, Kerst G, Gawaz M, Schreieck J. Herz. 2016;41:241-5.27. A case of very late single leaflet detachment after percutaneous edge-to-edge mitralvalve repair (PMVR). Nording H, Patzelt J, Walker T, Seizer P, GawazM, Schreieck J, Langer HF. Int J Cardiol. 2016;221:419-21.28. Percutaneous Mitral Valve Edge-to-Edge Repair With Simultaneous BiatrialIntracardiac Echocardiography: First-in-Human Experience. Patzelt J, Seizer P,Zhang YY, Walker T, Schreieck J, Gawaz M, Langer HF. Circulation.2016;133:1517-9.29. Successful Surgical Treatment of an Electrical Storm in a Patient With AtypicalNoncompaction Cardiomyopathy. Schibilsky D, Klingel K, Schreieck J, Gawaz M,Walker T, Schlensak C, Seizer P. Circ Heart Fail. 2016;9:e002973.30. Effects of Mechanical Ventilation on Heart Geometry and Mitral Valve LeafletCoaptation During Percutaneous Edge-to-Edge Mitral Valve Repair. Patzelt J, ZhangY, Seizer P, Magunia H, Henning A, Riemlova V, Patzelt TA, Hansen M, Haap M,Riessen R, Lausberg H, Walker T, Reutershan J, Schlensak C, Grasshoff C, SimonDI, Rosenberger P, Schreieck J, Gawaz M, Langer HF. JACC Cardiovasc Interv.2016;9:151-9.431. Insertable cardiac monitors after cryptogenic stroke - a risk factor based approach toenhance the detection rate for paroxysmal atrial fibrillation. Poli S, Diedler J, Härtig F,Götz N, Bauer A, Sachse T, Müller K, Müller I, Stimpfle F, Duckheim M, Steeg M,Eick C, Schreieck J, Gawaz M, Ziemann U, Zuern CS. Eur J Neurol. 2016;23:375-81.32. Postinterventional use of dabigatran in patients undergoing ablation therapy using anaccelerated loading dose scheme - a single center experience. Seizer P, Gramlich M,Frische C, Gawaz M, Schreieck J. Thromb Res. 2015;136:486-7.33. Anticoagulation after catheter ablation of atrial fibrillation guided by implantablecardiac monitors. Zuern CS, Kilias A, Berlitz P, Seizer P, Gramlich M, Müller K,Duckheim M, Gawaz M, Schreieck J. Pacing Clin Electrophysiol. 2015;38:688-93.34. Double Ventricular Responses Leading to Reversible Cardiomyopathy as LateComplication after Slow-Pathway Ablation. Celikyurt U, Gawaz M, Schreieck J,Seizer P. Case Rep Cardiol. 2015;2015:326576.35. Cardiac arrest saves a patient's procedure. Patzelt J, Seizer P, Walker T, Bauer A,Gawaz M, Schreieck J, Langer HF. Int J Cardiol. 2015;15:165-6.36. Randomized trial of atrial arrhythmia monitoring to guide anticoagulation in patientswith implanted defibrillator and cardiac resynchronization devices. Martin DT,Bersohn MM, Waldo AL, Wathen MS, Choucair WK, Lip GY, Ip J, Holcomb R, AkarJG, Halperin JL; IMPACT Investigators Schreieck J. Eur Heart J. 2015;36:1660-8.37. Comparison of 'anatomically designed' and 'point-by-point' catheter ablations forhuman atrial fibrillation in terms of procedure timing and costs in German hospitals.Klein G, Lickfett L, Schreieck J, Deneke T, Wieczorek M; FAST-PVI Study Group,Burkowitz J, Alvarez-Ossorio L, Brüggenjürgen B. Europace. 2015;17:1030-7.38. Sympathetic activity-associated periodic repolarization dynamics predict mortalityfollowing myocardial infarction. Rizas KD, Nieminen T, Barthel P, Zürn CS, KähönenM, Viik J, Lehtimäki T, Nikus K, Eick C, Greiner TO, Wendel HP, SeizerP, Schreieck J, Gawaz M, Schmidt G, Bauer A. J Clin Invest. 2014;124:1770-80.39. Percutaneous edge-to-edge mitral valve repair escorted by left atrial intracardiacechocardiography (ICE). Henning A, Mueller II, Mueller K, Zuern C, Walker T, GawazM, Schreieck J, Langer HF. Circulation. 2014;130:e173-4.40. Vaginal bleeding as symptom of a medical emergency--pitfalls of therapy with neworal anticoagulants - case 5/2014. Baumann D, Haap M, Tsaousidis C, KrämerB, Schreieck J, Jaschonek K, Rettig I, Peter A, Wallwiener D, Artunc F. Dtsch MedWochenschr.2014;139:1539.41. Rare cause of severely impaired left and right ventricular function--case 7/2014.Duckheim M, Bigalke B, Artunc F, Gawaz M, Schreieck J. Dtsch Med Wochenschr.2014;139:2136.42. Left ventricular site-directed biopsy guided by left ventricular voltage mapping: a proofof principle. Seizer P, Klingel K, Stickel J, Dorn C, Horger M, Kandolf R, Bigalke B,May AE, Gawaz M, Schreieck J. Int J Cardiol. 2013;168:3113-4.543. Electrophysiological characterization of scars detected by contrast enhancedmagnetic resonance imaging in patients with non-ischemic cardiomyopathy. Seizer P,Zuern CS, Maier J, Kerst G, Weig HJ, Gansser L, Kramer U, May AE, Parade U,Bigalke B, Bauer A, Gawaz M, Geisler T, Schreieck J. Int J Cardiol. 2013;167:1070-2.44. Reverse left ventricular remodeling after percutaneous mitral valve repair: strainanalysis by speckle tracking echocardiography and cardiac magnetic resonanceimaging. Zuern CS, Krumm P, Wurster T, Kramer U, Schreieck J, Henning A, BauerA, Gawaz M, May AE. Int J Cardiol. 2013;168:4983-5.45. Atrial reverse remodeling: restitution of early tachycardia-induced alterations of atrialion currents after termination of rapid atrial pacing in rabbits. Laszlo R, Konior A,Bentz K, Eick C, Schreiner B, Schreieck J, Bosch RF. Res Vet Sci. 2013;94:320-4.46. EMMPRIN and its ligand cyclophilin A as novel diagnostic markers in inflammatorycardiomyopathy.Seizer P, Geisler T, Bigalke B, Schneider M, Klingel K, Kandolf R,Stellos K, Schreieck J, Gawaz M, May AE. Int J Cardiol. 2013 Mar 10;163(3):299-30447. A novel technique for zero-fluoroscopy catheter ablation used to manage Wolff-Parkinson-White syndrome with a left-sided accessory pathway. Kerst G, Parade U,Weig HJ, Hofbeck M, Gawaz M, Schreieck J. Pediatr Cardiol. 2012;33:820-3.48. Efficacy of cut-and-sew box isolation of the posterior left atrium for treatment of atrialfibrillation-long-term follow-up after a modified maze procedure. Laszlo R, Graze H,Haas C, Kettering K, Aebert H, Ziemer G, Gawaz M, Schreieck J. Heart Surg Forum.2012;15:E28-33.49. Contact force-controlled zero-fluoroscopy catheter ablation of right-sided and leftatrial arrhythmia substrates. Kerst G, Weig HJ, Weretka S, Seizer P, Hofbeck M,Gawaz M, Schreieck J. Heart Rhythm. 2012;9:709-14.50. Very late stent thrombosis 5 years after IVUS-guided drug-eluting stent implantation.Sauter RJ, Steeg M, Bocksch W, Schreieck J, Gawaz M, Langer HF. Blood CoagulFibrinolysis. 2012;23:666-8.51. Drug-induced long QT syndrome. Relevancy in intensive care medicine. Laszlo R,Laszlo S, Kettering K, Schreieck J, Riessen R. Med Klin Intensivmed Notfmed.2012;107:200-5.52. Renal sympathetic denervation for treatment of electrical storm: first-in-manexperience. Ukena C, Bauer A, Mahfoud F, Schreieck J, Neuberger HR, Eick C,Sobotka PA, Gawaz M, Böhm M. Clin Res Cardiol. 2012;101:63-7.53. Contact force control - the key to safe zero-fluoroscopy catheter ablation ofatrioventricular nodal reentrant tachycardia. Kerst G, Weig HJ, Weretka S, Seizer P,Hofbeck M, Gawaz M, Schreieck J. Dtsch Med Wochenschr. 2011;136:1946-51.54. Effects of dexamethasone and atorvastatin on atrial sodium current and its earlytachycardia-induced electrical remodeling in rabbits. Laszlo R, Schwiebert M, MenzelKA, Eick C, Schreiner B, Schreieck J. Pak J Pharm Sci. 2011;24:383-7.655. Effects of aldosterone and mineralocorticoid receptor antagonism on cardiac ionchannels in the view of upstream therapy of atrial fibrillation. Laszlo R, BentzK, Schreieck J. Gen Physiol Biophys. 2011;30:11-9.56. Catheter ablation of persistent atrial fibrillation: anatomically based circumferentialpulmonary vein ablation in combination with a potential-guided segmental approachto achieve complete pulmonary vein isolation. Kettering K, Weig HJ, Busch M,Schneider KM, Eick C, Weretka S, Laszlo R, Gawaz M, Schreieck J. J Interv CardElectrophysiol. 2011;30:63-72.57. Successful bridge to recovery using a microaxial blood pump in a patient withelectrical storm and cardiogenic shock. Henning A, Schreieck J, Riessen R, GawazM, May AE. Med Klin Intensivmed Notfmed. 2011;106:132-6.58. Genetic Polymorphisms as Risk Stratification Tool in Primary Preventive ICDTherapy. Laszlo R, Busch MC, Schreieck J. ISRN Cardiol.;2011:457247.59. Percutaneous mitral valve repair using the MitraClip in acute cardiogenic shock.Zuern CS, Schreieck J, Weig HJ, Gawaz M, May AE Clin Res Cardiol. 2011Aug;100(8):719-21.60. Complex fractionated atrial electrogram or linear ablation in patients with persistentatrial fibrillation - a prospective randomized study. Estner HL, Hessling G, BieglerR, Schreieck J, Fichtner S, Wu J, Jilek C, Zrenner B, Ndrepepa G, Schmitt C,Deisenhofer I. Pacing Clin Electrophysiol. 2011;34:939-48.61. Catheter ablation of paroxysmal atrial fibrillation: extended recommendationsconsidering safety improvements of pulmonary vein isolation with acryoballoon--Case 11/2011. Weretka S, Weig HJ, Rüb N, Parade U, Kerst G,Laszlo R, Gawaz M, Schreieck J. Dtsch Med Wochenschr. 2011;136:243462. Influence of dexamethasone on atrial ion currents and their early ionic tachycardiainducedelectrical remodeling in rabbits. Laszlo R, Schwiebert M, Menzel KA,Schreiner B, Eick C, Bosch RF, Schreieck J. Cell Physiol Biochem. 2010;26:495-502.63. Electrical cardioversion for atrial fibrillation. Laszlo R, Laszlo S, GrazeH, Schreieck J. Dtsch Med Wochenschr. 2010;135:750-4.64. Atorvastatin treatment affects atrial ion currents and their tachycardia-inducedremodeling in rabbits. Laszlo R, Menzel KA, Bentz K, Schreiner B, Kettering K, EickC, Schreieck J. Life Sci. 2010;87:507-13.65. Effects of selective mineralocorticoid receptor antagonism on atrial ion currents andearly ionic tachycardia-induced electrical remodelling in rabbits. Laszlo R, Bentz K,Konior A, Eick C, Schreiner B, Kettering K, Schreieck J. Naunyn SchmiedebergsArch Pharmacol. 2010;382:347-56.66. Catheter ablation of ventricular tachycardias in patients with ischemiccardiomyopathy: validation of voltage mapping criteria for substrate modification bymyocardial viability assessment using FDG PET. Kettering K, Weig HJ, Reimold M,Schwegler AC, Busch M, Laszlo R, Gawaz M, Schreieck J. Clin Res Cardiol.2010;99:753-60.767. Atrial fibrillation - Links between principles of pathophysiology and treatment. LaszloR, Graze H, Laszlo S, Schreieck J. Dtsch Med Wochenschr. 2010;135:862-7.68. Risk stratification in non ischemic cardiomyopathy: a case report--Case 5/2010.Parade U, Klingel K, Kandolf R, Gawaz M, Schreieck J. Dtsch Med Wochenschr.2010;135:1122.69. Alcohol-induced electrical remodeling: effects of sustained short-term ethanol infusionon ion currents in rabbit atrium. Laszlo R, Eick C, Schwiebert M, Schreiner B, WeigHJ, Weretka S, Bosch RF, Schreieck J. Alcohol Clin Exp Res. 2009;33:1697-703.70. Percutaneous closure of a periprosthetic leakage after mitral valve reoperation due torecurrent endocarditis. Kuehl M, Schreieck J, Burgstahler C. Catheter CardiovascInterv. 2009;73:838-41.71. Inactivation of the intracardial cardioverter/defibrillator (ICD) antitachycardial functionin dilated cardiomyopathy. Driver can again work in her occupation. Laszlo R, EickC, Schreieck J. Dtsch Med Wochenschr. 2009;134:1578-81.72. Catheter ablation of atrial fibrillation using the Navx-/Ensite-system and a CT-/MRIguidedapproach. Kettering K, Greil GF, Fenchel M, Kramer U, Weig HJ, Busch M,Miller S, Sieverding L, Laszlo R, Schreieck J. Clin Res Cardiol. 2009;98:285-96.73. Transient outward potassium current in rabbit atrium is depressed after short-timerapid atrial pacing but recovers after a longer pacing period. Laszlo R, Eick C,Schwiebert M, Schreiner B, Weig HJ, Weretka S, Schreieck J. Gen Physiol Biophys.2008;27:174-8.74. Segmental pulmonary vein ablation: success rates with and without exclusion ofareas adjacent to the esophagus. Kettering K, Weig HJ, Busch M, LaszloR, Schreieck J. Pacing Clin Electrophysiol. 2008;31:652-9.75. Narrow complex tachycardia with alternating R-R intervals during physical stress:double ventricular excitation. Laszlo R, Weig HJ, Weretka S, Schreieck J. IndianPacing Electrophysiol J. 2008;8:129-32.76. Cardiac resynchronization therapy in non-ischemic cardiomyopathy. Weretka S, RübN, Weig HJ, Laszlo R, Dörnberger V, Gawaz M, Schreieck J. Dtsch MedWochenschr. 2008;133 Suppl:F2.77. Interatrial lipoma: catheter ablation of an atrial tachycardia originating from adislodged arrhythmogenic substrate assisted by a three-dimensional mapping systemwith a combined synchronized three-dimensional CT reconstruction. Kettering K, GreilGF, Busch M, Kramer U, Fenchel M, Miller S, Sieverding L, Schreieck J. Clin ResCardiol. 2007;96:396-9.78. Catheter ablation of atrial fibrillation: ongoing atrial fibrillation inside a singlepulmonary vein after successful electrical disconnection and restoration of sinusrhythm in both atria. Kettering K, Greil GF, Busch M, Miller S, SieverdingL, Schreieck J. Clin Res Cardiol. 2006;95:663-7.879. Schreieck J, Hessling G, Pustowoit A, Schmitt C, Ventricular tachycardia. In SchmittC, Deisenhofer I, Zrenner B, (eds): Catheter Ablation of Cardiac Arrhythmias.Steinkopf: Darmstadt, 2006, pp 183-21080. Deisenhofer I, Estner H, Zrenner B, Schreieck J, Weyerbrock S, Hessling G, ScharfK, Karch MR, Schmitt C. Left atrial tachycardia after circumferential pulmonary veinablation for atrial fibrillation: incidence, electrophysiological characteristics, andresults of radiofrequency ablation. Europace 2006;8:573-582.81. Kettering K, Greil G, Busch M, Miller S, Sieverding L, Schreieck J. Catheter ablationof atrial fibrillation: ongoing atrial fibrillation inside a single pulmonary vein aftersuccessful electrical disconnection and restoration of sinus rhythm in both atria. ClinRes Cardiol 2006, 95:1-5.82. Schreieck J, Zrenner B, Deisenhofer I, Schmitt C. Rescue ablation of electrical stormin patients with diffuse myocardial infarction: an potential-guided ablation approach bymodifying substrate of intractable, unmappable ventricular tachycardias. HeartRhythm 2005,2:10-14.83. Karch MR, Zrenner B, Deisenhofer I, Schreieck J, Ndrepepa G, Dong J, LamprechtK, Barthel P, Luciani E, Schömig A, Schmitt C. Freedom from atrial tachyarrhythmiaafter catheter ablation of atrial fibrillation: a randomized comparison between 2current ablation strategies. Circulation 2005; 111:2875-2880.84. Dong J, Zrenner B, Schreieck J, Deisenhofer I, Karch M, Schneider M, von Bary C,Weyerbrock S, Yin Y, Schmitt C. Catheter ablation of left atrial focal tachycardiaguided by electroanatomic mapping and new insights into interatrial electricalconduction. Heart Rhythm 2005; 2:578-591.85. Estner HL, Ndrepepa G, Dong J, Deisenhofer I, Schreieck J, Schneider M, PlewanA, Karch M, Weyerbrock S, Wade D, Zrenner B, Schmitt C. Acute and long-termresults of slow pathway ablation in patients with atrioventricular nodal reentranttachycardia – an analysis of the predictive factors for arrhythmia recurrence. PacingClin Electrophysiol 2005,28:102-110.86. Hager A, Zrenner B, Brodherr-Heberlein S, Steinbauer-Rosenthal I, Schreieck J,Hess J. Congenital and surgically acquired Wolff-Parkinson-White syndrome inpatients with tricuspid atresia. J Thorac Cardiovasc Surg 2005; 130: 48-53.87. Dong J, Zrenner B, Schreieck J, Schmitt C. Necessity for biatrial ablation to achievebidirectional cavotricuspid isthmus conduction block in a patient following senningoperation. J Cardiovasc Electrophysiol 2004;15:945-949.88. Zrenner B, Dong J, Schreieck J, Deisenhofer I, Estner H, Luani B, Karch M, SchmittC. Transvenous cryoablation versus radiofrequency ablation of the slow pathway forthe treatment of atrioventricular nodal re-entrant tachycardia: a prospectiverandomized pilot study. Eur Heart J 2004;25:2226-2231.89. Schreieck J, Dostal S, von Beckerath N, Wacker A, Flory M, Weyerbrock S, Koch W,Schömig A, Schmitt C. C825T polymorphism of the G-protein ß3 subunit gene andatrial fibrillation: association ot the TT genotype with a reduced risk for atrialfibrillation. Am Heart J 2004;148:545-550.990. Zrenner B, Dong J, Schreieck J, Ndrepepa G, Meisner H, Kaemmerer H, Schömig A,Hess J, Schmitt C. Delineation of intra-atrial reentrant tachycardia circuits aftermustard operation for transposition of the great arteries using biatrial electroanatomicmapping and entrainment mapping. J Cardiovasc Electrophysiol 2003;14:1302-1310.91. Schneider MA. Ndrepeoa G. Dobran I, Schreieck J, Weber S, Plewan A,Deisenhofer I, Karch MR, Schömig A, Schmitt C. LocaLisa catheter navigationreduces fluoroscopy time and dosage in ablation of atrial flutter: a prospectiverandomized study. J Cardiovasc Electrophysiol 2003;14:587-590.92. Ndrepepa G, Schneider MA, Karch MR, Weber S, Schreieck J, Schömig A, SchmittC. Pulmonary vein internal electrical activity does not contribute to the maintenanceof atrial fibrillation. Pacing Clin Electrophysiol 2003;26:1356-1362.93. Karch MR, Ndrepepa G, Schneider MA, Weber S, Schreieck J, Schmitt C. Singlechamber atrial fibrillation involving only the left atrium: implications for maintenanceand radiofrequency ablation therapy. Pacing Clin Electrophysiol 2003;26:883-891.94. Ndrepepa G, Schneider MA, Karch MR, Weber S, Schreieck J, Zrenner B, SchmittC. Impact of atrial fibrillation on the voltage of bipolar signals acquired from the leftand right atria. Pacing Clin Electrophysiol 2003;26:862-869.95. Schmieder S, Ndrepepa G, Dong J, Zrenner B, Schreieck J, Schneider MA, KarchMR, Schmitt C. Acute and long-term results of radiofrequency ablation of commonatrial flutter and the influence of the right atrial isthmus ablation on the occurrence ofatrial fibrillation. Eur Heart J 2003;24:956-962.96. Weber S, Ndrepepa G, Schneider M, Geissler B, Schreieck J, Karch M, SchmiederS, Deisenhofer I, Zrenner B, Schömig A, Schmitt C. Characterization of onsetmechanism and waveform analysis in patients with atrial fibrillation using a highresolutionnoncontact mapping system. J Cardiovasc Electrophysiol 2003;14:176-181.97. Kolb C, Lehmann G, Schreieck J, Ndrepepa G, Schmitt C. Storms of ventriculartachyarrhythmias associated with primary hyperparathyroidism in a patient withdilated cardiomyopathy. Int J Cardiol 2003;87:115-116.98. Kolb C, Zrenner B, Schreieck J, Schmitt C. Strategies to avoid inappropriatetherapies due to ventricular double detection in biventricular pacing implantablecardioverter/defibrillators. Eur J Heart Fail 2003;5:523-526.99. Deisenhofer I, Schneider MA; Bohlen-Knauf M, Zrenner B, Ndrepepa G, SchmiederS, Weber S, Schreieck J, Weyerbrock S, Schmitt C. Circumferential mapping andelectrical isolation of pulmonary veins in patients with atrial fibrillation. Am J Cardiol2003;91:159-63.100. Schreieck J, Zrenner B, Kumpmann J, Ndrepepa G, Schneider MAE,Deisenhofer I, Schmitt C: Prospective randomized comparison of closed cooled-tipversus 8mm-tip catheters for radiofrequency ablation of typical atrial flutter. JCardiovasc Electrophysiol 2002;13:980-985.10101. Dong J, Schreieck J, Ndrepepa G, Schmitt C: Ectopic tachycardia originatingfrom the superior vena cava. J Cardiovasc Electrophysiol 2002;13:620-624.102. Schreieck J, Zrenner B, Dong J, Ndrepepa G, Schmitt C: Dissimilar atrial rhythms:coexistence of reentrant atrial tachycardia, atrioventricular nodal reentranttachycardia and interatrial conduction block. Z Kardiol 2002;91:68-73.103. Schmitt C, Ndrepepa G, Weber S, Schmieder S, Weyerbrock S, Schneider M, KarchMR, Deisenhofer I, Schreieck J, Zrenner B, Schömig A. Biatrial multisite mapping ofatrial premature complexes triggering onset of atrial fibrillation. Am J Cardiol2002;89:1381-1387.104. Schreieck J, Ndrepepa G, Zrenner B, Schneider MAE, Weyerbrock S, Dong J,Schmitt C: Radiofrequency ablation of cardiac arrhythmias using a new threedimensionalreal-time position management and mapping system. Pacing ClinElectrophysiol 2002;25:1699-1707.105. Schneider MA, Zrenner B, Karch MR, Weverbrock S, Schreieck J, Ndrepepa G,Schömig A, Schmitt C. Direct and indirect catheter-to-catheter carbonization causedby high power radiofrequency delivery via a large tip ablation electrode. J IntervCardiol 2002;15:407-410.106. Ndrepepa G, Karch MR, Schneider MA, Weyerbrock S, Schreieck J, Deisenhofer I,Zrenner B, Schömig A, Schmitt C: Characterization of paroxysmal and persistentatrial fibrillation in the human left atrium during initiation and sustained episodes. JCardiovasc Electrophysiol 2002;13:525-532.107. Schmitt C, Ndrepepa G, Weber S, Schmieder S, Weyerbrock S, Schneider M,Karch MR, Deisenhofer I, Schreieck J, Zrenner B, Schömig A: Biatrial multisitemapping of atrial premature complexes triggering onset of atrial fibrillation. Am JCardiol 2002;89:1381-1387.108. Schneider MAE, Ndrepepa G, Zrenner B, Karch MR, Schmieder S, Deisenhofer I,Schreieck J, Schömig A, Schmitt C: Noncontact mapping-guided ablation of atrialflutter and enhanced-density mapping of the inferior vena caval-tricuspid annulusisthmus. Pacing Clin Electrophysiol 2001;24:1755-1764.109. Schreieck J, Zrenner B, Kolb C, Ndrepepa G, Schmitt C: Inappropriate shockdelivery due to ventricular double detection with a biventricular pacing implantablecardioverter defibrillator. Pacing Clin Electrophysiol 2001;24:1154-1157.110. Zrenner B, Ndrepepa G, Karch MR, Schneider MA, Schreieck J, Schömig A,Schmitt C: Electrophysiologic characteristics of paroxysmal and chronic atrialfibrillation in human right atrium. J Am Coll Cardiol 2001;38:1143-1149.111. Plewan A, Lehmann G, Ndrepepa G, Schreieck J, Alt EU, Schömig A, Schmitt C:Maintenance of sinus rhythm after electrical cardioversion of persistent atrialfibrillation; sotalol vs bisoprolol. Eur Heart J 2001;22:1504-1510.11112. Ndrepepa G, Zrenner B, Schneider MA, Schreieck J, Karch MR, Schömig A,Schmitt C: Dissociation between coronary sinus and left atrial conduction in patientswith atrial fibrillation and flutter. J Cardiovasc Electrophysiol 2001;12:623-628.113. Schmitt C, Barthel P, Ndrepepa G, Schreieck J, Plewan A, Schömig A, SchmidtG: Value of programmed ventricular stimulation for prophylactic internal cardioverterdefibrillatorimplantation in postinfarction patients preselected by noninvasive riskstratifiers. J Am Coll Cardiol 2001;37:1901-1907.114. Deisenhofer I, Kolb C, Ndrepepa G, Schreieck J, Karch M, Schmieder S,Zrenner B, Schmitt C: Do current dual chamber cardioverter defibrillators haveadvantages over conventional single chamber cardioverter defibrillators in reducinginappropriate therapies? A randomized, prospective study. J CardiovascElectrophysiol 2001;12:134-142.115. Tölg R, Schreieck J, Kurz T, Katus HA, Richardt G: Ischemia-induced ventricularfibrillation in isolated perfused rat heart: role of alpha1A-adrenoceptor mediatedactivation of protein kinase C. Basic Res Cardiol 2001;96:68-74.116. Ndrepepa G, Schneider MA, Vallaint A, Zrenner B, Karch MR, Schreieck J,Henke J, Schömig A, Schmitt C: Acute electrophysiologic effects and antifibrillatoryactions of the long linear lesions in the right atrium in a sheep model. J Interv CardElectrophysiol 2000;4:529-536.117. Schreieck J, Wang Y, Overbeck M, Schömig A, Schmitt C: Altered transientoutward current in human atrial myocytes of patients with reduced left ventricularfunction. J Cardiovasc Electrophysiol 2000;11:180-192.118. Zrenner B, Ndrepepa G, Schneider M, Karch M, Deisenhofer I, Schreieck J,Schömig A, Schmitt C: Basket catheter-guided three-dimensional activation patternsconstruction and ablation of common type atrial flutter. Pacing Clin Electrophysiol2000;23:1350-1358.119. Ndrepepa G, Zrenner B, Deisenhofer I, Karch M, Schneider M, Schreieck J,Schmitt C: Relationship between surface electrocardiogram characteristics andendocardial activation sequence in patients with typical atrial flutter. Z Kardiol2000;89:527-537.120. Ndrepepa G, Zrenner B, Schreieck J, Karch MR, Schneider MA, Schömig A,Schmitt C: Left atrial fibrillation with regular right atrial activation and a single left-torightelectrical interatrial connection: multisite mapping of dissimilar atrial rhythms. JCardiovasc Electrophysiol 2000;11:587-592.121. Schneider MA, Ndrepepa G, Zrenner B, Karch MR, Schreieck J, Deisenhofer I,Schmitt C: Noncontact mapping-guided catheter ablation of atrial fibrillationassociated with left atrial ectopy. J Cardiovasc Electrophysiol 2000;11:475-479.122. Schmitt C, Schreieck J, Zrenner B. Are newer class 3 antiarrhythmic drugsbetter? Experimental and clinical data. In Franz MR (ed): Monophasic actionpotentials: Bridging cell and bedside. Futura Publishing Co inc, Armonk New York,2000, pp 365-386123. Schmitt C, Zrenner B, Schneider M, Karch M, Ndrepepa G, Deisenhofer I,Weyerbrock S, Schreieck J, Schömig A: Clinical experience with a novel12multielectrode basket catheter in right atrial tachycardias. Circulation 1999;99:2414-2422.124. Schreieck J, Richardt G: Endogenous adenosine reduces the occurrence ofischemia-induced ventricular fibrillation in rat heart. J Mol Cell Cardiol 1999;31:123-134.125. Zrenner B, Müssig D, Schreieck J, Weyerbrock S, Schneider M, Schaldach M,Schömig A, Schmitt C: Intraoperative recordings of monophasic action potentials withchronically implantable pacemaker leads. Pacing Clin Electrophysiol 1998;21:235-238.126. Gjini V, Schreieck J, Korth M, Weyerbrock S, Schömig A, Schmitt C: Frequencydependence in the action of the class III antiarrhythmic drug dofetilide is modulatedby altering L-type calcium current and digitalis glucoside. J Cardiovasc Pharmacol1998;31:95-100.127. Weyerbrock S, Schreieck J, Karch M, Overbeck M, Meisner H, Kemkes B,Schömig A, Schmitt C: Rate-independent effects of the new class III antiarrhythmicagent ambasilide on transmembrane action potentials in human ventricularendomyocardium. J Cardiovasc Pharmacol 1997;30:571-575.128. Schmitt C, Schreieck J, Karch M, Zrenner B. Frequency-dependent effects ofclass III antiarrhythmic agents as assessed by MAP recordings – possible advantageof IKs blockade. In Franz MR, Schmitt C, Zrenner B (eds): Monophasic actionpotentials. Basic and clinical application. Springer-Verlag, Berlin-Heidelberg-NewYork, 1997, pp 85-96129. Tölg R, Kurz T, Ungerer M, Schreieck J, Görge B, Richardt G: Influence ofalpha- and beta-adrenoceptor antagonists on ventricular fibrillation in ischemic rathearts. Naunyn Schmiedebergs Arch Pharmacol 1997;356:62-68.130. Zrenner B, de la Chaux R, Schreieck J, Schneider M, Schmitt C (1997)Recording of monophasic action potentials with fractally coated electrodes –Experimental and initial clinical results. In: Franz MR, Schmitt C, Zrenner B (eds):Monophasic action potentials. Basic and clinical application. Springer Verlag, BerlinHeidelberg New York, 1997, pp 58-68131. Schreieck J, Wang Y, Gjini V, Korth M, Zrenner B, Schömig A, Schmitt C:Differential effect of beta-adrenergic stimulation on the frequency-dependentelectrophysiologic actions of the new class III antiarrhythmics dofetilide, ambasilide,and chromanol 293B. J Cardiovasc Electrophysiol 1997;8:1420-1430.132. Richardt G, Ungerer M, Münch G, Schreieck J, Kurz T: Interactions of adenosinewith sympathetic neurotransmission: protective effect in myocardial ischemia. J AutonPharmacol 1996;16:333-335.133. Gjini V, Korth M, Schreieck J, Weyerbrock S, Schömig A, Schmitt C: Differentialclass III antiarrhythmic effects of ambasilide and dofetilide at different extracellularpotassium and pacing frequencies. J Cardiovasc Pharmacol 1996;28:314-320.134. Kurz T, Offner B, Schreieck J, Richardt G, Tölg R, Schömig A: Nonexocytoticnoradrenaline release and ventricular fibrillation in ischemic rat hearts. NaunynSchmiedebergs Arch Pharmacol 1995;352:491-496.13135. Zong X, Schreieck J, Mehrke G, Welling A, Schuster A, Bosse E, Flockerzi V,Hofmann F: On the regulation of the expressed L-type calcium channel by cAMPdependentphosphorylation. Pflügers Arch 1995;430:340-347.
  • Wahlfach Rhythmolgie
  • Wahlfach interventionelle Kardiologie
  • Deutsche Gesellschaft für Kardiologie (DGK)
  • European Heart Rhythm Association (EHRA)